ArticleAnnals of surgical oncology2026
Tumor Laterality Predicts Pelvic Lymph Node Metastasis Patterns in Bladder Cancer.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough lymph node involvement (LNI) is a critical prognostic factor guiding adjuvant therapy, randomized trials have failed to show a survival advantage of extended versus standard pelvic lymph node dissection (PLND) but have demonstrated increased morbidity. Refining PLND templates according to tumor characteristics, such as laterality, may improve the risk-benefit balance. This study aimed to clarify the relationship between bladder tumor location and the anatomical distribution of LNI in bladder cancer. PATIENTS AND
methodsWe retrospectively reviewed 102 patients who underwent radical cystectomy with bilateral extended PLND at Kyushu University Hospital between 2013 and 2024. Tumor laterality was classified as unilateral or bilateral. LNI sites were categorized as ipsilateral versus contralateral and by level (I: obturator, internal/external iliac; II: common iliac, presacral).
resultsOverall, 17.6% of patients had LNI. Bilateral tumors were associated with higher nodal metastasis than were unilateral tumors (24.2% vs. 14.5%). In unilateral tumors, contralateral LNI without ipsilateral involvement occurred in only 1.5% of cases. Level II metastasis was uncommon (5.9%), and skip metastasis to level II nodes without level I involvement was rare (1.0%).
conclusionsTumor laterality is a strong predictor of nodal distribution. The rarity of contralateral or skip metastasis warrants prospective studies to validate tailored, tumor location-based PLND strategies.
Indexed as
Identifiers
41545612What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.